Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: A randomized, double-blind 52-week comparison

Joseph P. McEvoy, Jeffrey A. Lieberman, Diana O. Perkins, Robert M. Hamer, Hongbin Gu, Arthur Lazarus, Dennis Sweitzer, Christina Olexy, Peter Weiden, Stephen D. Strakowski

Research output: Contribution to journalArticlepeer-review

312 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: A randomized, double-blind 52-week comparison'. Together they form a unique fingerprint.

Medicine & Life Sciences